Postdoctoral Research Symposium Postdoctoral researchers share their findings with colleagues and interact with scientists 
|
|
|
Memorial Sloan-Kettering postdoctoral researchers got the chance to showcase their accomplishments at the second annual Postdoctoral Research Symposium, held in Memorial Sloan-Kettering Cancer Center's Rockefeller Research Laboratories in late October. The event allowed postdocs to share their latest findings with Memorial Sloan-Kettering colleagues, mentors, and other members of the Tri-Institutional community.
More than 80 scientific projects were described through oral presentations and poster discussions during the daylong event. The symposium culminated with a keynote address by Christine Guthrie, a leading RNA researcher and a professor of biochemistry at the University of California, San Francisco (UCSF).
"This symposium is an outstanding venue for allowing postdoctoral researchers to spotlight their work and interact with other members of the research community," said Sloan-Kettering Institute Director Thomas J. Kelly. "If anything, this year's event surpassed the success of our first symposium, which was very well received."
With the addition of oral presentations and a poster competition, the 2008 program expanded on the agenda of the inaugural symposium, held in October 2007, which drew an enthusiastic crowd and concluded with a keynote address by Nobel Laureate Paul M. Nurse, President of The Rockefeller University.
That 2007 symposium made a strong impression on cell biologist Mandana Namdar when she read a Center News article about the event on the Memorial Sloan-Kettering Web site. "I was reading about life as a postdoc at Sloan-Kettering, and the symposium sounded like a great initiative to promote the varied and extensive research at the Center, as well as foster interactions between members of the postdoctoral community," she said.
At the time, Dr. Namdar had recently completed her PhD at Oxford University and was strongly considering accepting a postdoctoral position at Sloan-Kettering Institute. "Sloan-Kettering already appealed strongly to me because it's set up perfectly for the basic and translational cancer research that I was planning to pursue," she added.
In early 2008 Dr. Namdar accepted a position in the laboratory of Memorial Sloan-Kettering President Emeritus Paul A. Marks. For her research, she explores the mechanisms of action of histone deacetylase, or HDAC, inhibitors, which interfere with the regulation of gene expression in cancer cells, blocking their growth and triggering self-destruction. But her activities extend beyond the laboratory and encompass many aspects of the postdoctoral experience at Sloan-Kettering Institute. "I enjoyed organizing events at Oxford, and I wanted to continue contributing to similar activities here at Memorial Sloan-Kettering," she explained.